Ambiq Micro Bets Big on Edge AI Growth

Ambiq Micro, Inc. ((AMBQ)) has held its Q4 earnings call. Read on for the main highlights of the call.

Ambiq Micro’s latest earnings call struck a cautiously optimistic tone as management highlighted record quarterly sales, sharply higher gross margins, and a fortified balance sheet, even as full‑year revenue slipped and losses persisted. Executives emphasized strong traction in edge AI and confidence in 2026 demand, but also acknowledged heavier spending and supply‑chain costs that could weigh on near‑term profitability.

Record Quarter Caps a Mixed Revenue Year

Ambiq reported Q4 2025 net sales of $20.7 million, up 2% year over year and 14.2% sequentially, marking its strongest quarter of the year and beating guidance. The solid finish contrasted with a 4.7% decline in full‑year net sales, underscoring that the company’s improvement is coming more from mix and execution than from broad‑based top‑line growth so far.

Margins Surge as Gross Profit Scales

Non‑GAAP gross profit jumped 75.5% in Q4 to $9.4 million, with gross margin expanding nearly 20 percentage points to 45.5%, driven by a richer product mix and better pricing. For 2025 as a whole, non‑GAAP gross profit dollars rose 32.1%, signaling that Ambiq is converting a smaller revenue base into significantly more gross earnings and improving its economic model.

Cash War Chest and Capital Raises Extend Runway

The company ended the quarter debt‑free with $140.3 million in cash and cash equivalents, largely from its IPO proceeds, giving it substantial flexibility to fund R&D and go‑to‑market efforts. A follow‑on equity offering added another $76.8 million, providing a sizable buffer as Ambiq steps up investment ahead of expected customer ramps and new product launches.

Strategic Shift Boosts Revenue Quality

Management has deliberately pivoted toward customers deploying edge AI, reducing Mainland China exposure from roughly half of 2024 net sales to just 8.6% in Q4 2025. This repositioning supports a more diversified, higher‑margin revenue base and less geopolitical risk, with a product mix that increasingly favors advanced, AI‑centric solutions rather than legacy or lower‑end designs.

Product Pipeline and Software Stack Gain Momentum

Ambiq expanded its Apollo line with the Apollo 510 Lite, Apollo 510B, and Apollo 330, targeting ultra‑low‑power use cases that are central to its strategy. On the software side, it rolled out Helia AOT and Helia RT AI runtimes and unveiled Atomic, its first SPOT family on TSMC FinFET technology, designed to run advanced AI workloads at voltages as low as 300 mV.

Broadening Customer Base and Edge AI Adoption

In 2025, the company widened its customer roster, including a major wearable client and more engagements in medical, industrial, and smart home and building markets. Ambiq estimates that more than 80% of units shipped during the year ran AI algorithms, suggesting that edge AI is no longer a niche feature but a central driver of its volume and value proposition.

Losses Narrow but Profitability Still Out of Reach

Despite better gross margins, Ambiq remains loss‑making on a non‑GAAP basis, with Q4 non‑GAAP net loss attributable to common stockholders at $5.9 million, an improvement from the prior year. Non‑GAAP loss per share of $0.32 reflects the ongoing drag from elevated operating expenses, highlighting that scaling revenue and controlling spend will be key to turning the corner.

Step‑Up in Operating Expenses to Fuel Growth

Non‑GAAP R&D expense climbed 33% year over year in Q4 to $9.3 million, while non‑GAAP SG&A rose 19.7% to $7.3 million, underscoring the cost of pushing deeper into AI silicon and software. Looking ahead, management expects non‑GAAP operating expenses to increase by roughly $30 million in 2026 as it accelerates product development and supports a growing customer pipeline.

Margin and Cash‑Flow Volatility on the Horizon

Executives warned that industry‑wide fab pricing and supply‑chain inflation could pressure gross margins, especially in the back half of the year, potentially slowing the pace of margin expansion. At the same time, Ambiq plans $7 million to $10 million of IP purchases in 2026 and project‑driven contract engineering spend, concentrated in Q2 and Q3, which may cause lumpy operating expenses and uneven cash‑flow patterns.

Strong 2026 Setup but Near‑Term Visibility Hazy

Management described 2026 as an inflection year, pointing to strong customer forecasts, migration to Apollo 5, and a path to more than $100 million in revenue as ramps mature. Yet, the CFO also outlined near‑term net sales of only $21.0 million to $22.0 million, a gap that introduces modeling uncertainty for investors trying to reconcile immediate guidance with management’s more ambitious multi‑year growth narrative.

Guidance Signals Investment Phase Before Payoff

For 2026, Ambiq guided to net sales of $21.0 million to $22.0 million, with non‑GAAP gross margin between 44% and 45% and non‑GAAP operating expense of $18.0 million to $18.5 million, implying a non‑GAAP loss per share of $0.39 to $0.33. Management stressed that operating expenses will run about $30 million above 2025 levels, including sizable IP purchases and project‑weighted spending, while growth is expected to be driven by new model launches, larger customer ramps, higher volumes, and broader Apollo 5 uptake.

Ambiq’s earnings call painted a picture of a company trading near‑term earnings stability for longer‑term growth and market share in edge AI, backed by a strong balance sheet and expanding product suite. Investors in the stock will need to balance the clear progress in margins, diversification, and design wins against rising expenses, margin headwinds, and guidance ambiguity as they assess when today’s investment cycle will translate into sustainable profitability.